|
Market Cap (23-May) $4,114,900 (1,059th) |
Close (30-Jun) $0.010 |
Volume (30-Jun) 1,641,703 |
Shortsold (24-Jan) 39,007 (0.00%) (630th) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
PAB released this announcement to the ASX on 28 April 2021, 17:52. The announcement is not marked as price sensitive, and is 17 page(s) in length and 546.59kb in size.
You can view all announcements from PAB and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAB was 0.024% short sold according to ASIC data. It was ranked the 560th most shorted stock on the ASX. It remains ranked 630th as of the latest reported data (24 January 2025).
| Other Recent Announcements from PAB | |
|---|---|
| PAT-DX1 GLP toxicology reports received | 24 May 2023, 9:12 |
| Notification regarding unquoted securities - PAB | 11 May 2023, 14:04 |
| Appendix 4C - Quarterly - 31 March 2023 | 24 April 2023, 10:10 |
| S708A Cleansing Notice and Appendix 2A | 28 April 2021, 17:52 |
| Appendix 4C - Quarterly - 31 March 2021 | 28 April 2021, 9:08 |
| Patrys completes PAT-DX1 and PAT-DX3 pharmacokinetic studies | 22 April 2021, 9:13 |
| New United States patent granted for Patrys' deoxymab assets | 31 March 2021, 9:35 |
You must be logged in to post a reply.
Patrys 